Mardiah Suci Hardianti

12PUBLICATIONS
31CO-AUTHORS
Epidemiological methodsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 23, 2026
Direct and Indirect Associations of Sociodemographic Factors and Patient-Perceived Barriers With Delayed Breast Cancer Presentation: A Cross-Sectional Path Analysis.

|Jun 16, 2026
Hematologic Malignancies of Primary Bone Marrow Origin in Adults: The Incidence and Profile in Eleven Years From One National Tertiary Referral Hospital in Indonesia.

|Apr 28, 2026
Adverse Prognostic Significance of Activation-Induced Cytidine Deaminase in Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP.

|Jun 21, 2025
Development of Nomogram for Predicting the Overall Survival of Diffuse Large B-Cell Lymphoma (DLBCL) Patients Based on Clinical Data and Systemic Inflammation Markers.

Sulasri Suddin, Mardiah Suci Hardianti, Fajar Adi-Kusumo

|Mar 31, 2025
Patterns, Predictors, and Prognostic Implication of Treatment-Related Amenorrhea in Patients With Breast Cancer.

Bryant Ng, Armeyra Devani Ferintasari, Susanna Hilda Hutajulu

|Jan 28, 2025
Severe Deficiency of Vitamin D and Anthracycline-Taxane Regimen are associated with Cachexia Following Breast Cancer Chemotherapy: A Single Center Assessment Using Two Consensus-Based Criteria.

Susanna Hilda Hutajulu, Sofi Aresy, Yufi Kartika Astari

Pageof 2

Frequent Collaborators

5 joint publications

Kartika Widayati Taroeno-Hariadi

4 joint publications

Susanna Hilda Hutajulu

3 joint publications

Johan Kurnianda

3 joint publications

Ibnu Purwanto